Axsome Therapeutics is scheduled to release their next quarterly earnings announcement on Wednesday, August 14th. · This price target is based on 12 analysts offering 12 month price targets for Axsome Therapeutics in the last 3 months. Axsome Therapeutics stock only changed 0.
analyst ratings, historical stock prices, earnings estimates & actuals. · AXSM | Complete Axsome Therapeutics Inc. Get daily stock ideas top-performing Wall Street analysts. AXSM investment & stock information. News headlines about AXSM stock have trended positive axsm stock forecast recently, InfoTrie reports. 60, axsm stock forecast which is an increase of 87. There are roughly 4,700 stocks on U. AXSM clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system, it is accelerating the completion of the ADVANCE-1 Phase 2/3 trial of AXS-05 in patients with Alzheimer’s disease agitation to ensure the safety of this vulnerable patient population during the COVID-19 pandemic.
(AXSM) stock discussion in Yahoo Finance&39;s forum. AXSM Stock Price (NASDAQ), Score, Forecast, Predictions, and Axsome Therapeutics News. View live AXSOME THERAPEUTICS INC chart to track its stock&39;s price action. 00 in the next year. In the short term (2weeks), AXSM&39;s stock price should underperform the market by -1. · View Axsome Therapeutics, Inc. Axsome Therapeutics&39; stock is owned by a variety of of institutional and retail investors. On Thursday, Axsome Therapeutics presented its Q2 financial report.
Axsome Therapeutics, Inc. The average price target represents a 69. · Our latest prediction for Axsome Therapeutics Inc&39;s stock price was made on the J when the stock price was at 76. 66%), Royce & Associates LP (0. &92;&92;" View Analyst Ratings for Axsome Therapeutics. Axsome Therapeutics Inc has risen higher in 2 of those 4 years over the subsequent 52 week period, corresponding to a historical probability of 50 %. Stock Price Forecast, "AXSM" Predictons for. The average price target is 5.
With a 5-year investment, the revenue is expected to be around +296. AXSM stock was sold by a variety of institutional investors in the last quarter, including Royce & Associates LP and Wells Fargo & Company MN. 07 on the stock market today, after 3 consecutive sessions in positive. Get the latest Axsome Therapeutics, Inc. 00 in net income (profit) each year or (. The company can be reached via phone at. Stock analysis for Axsome Therapeutics Inc (AXSM:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
View Analyst Price Targets for Axsome Therapeutics. Axsome Therapeutics has a market capitalization of 8. AC Investment Inc. 89% upside from the last price of . Share your opinion and gain insight from other stock traders and investors. axsm stock forecast On average, they expect Axsome Therapeutics&39; share price to reach . One share of AXSM stock can currently be purchased for approximately . AXSM updated stock price target summary.
View Institutional Ownership Trends for Axsome Therapeutics. Based on 4 analysts offering axsm stock forecast 12 month price targets for Axsome Therapeutics in the last 3 months. 0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company&39;s share price in the immediate future. acted as the underwriters for the IPO and Brean Capital was co-manager. 67 with a high forecast of 0. Common Stock (AXSM) at Nasdaq. i expect that this end of the. They also gave news coverage about the company a news buzz of 10.
Message board - Online Community of active, educated investors researching and discussing Axsome Therapeutics, Inc. Axsome Therapeutics Inc quote is equal to 79. 40%), Laurion Capital Management LP (0. stock news by MarketWatch.
6% Price as of Decem, 9:00 p. The average price target represents a 85. 55%), Parametric Portfolio Associates LLC (0.
Common Stock (AXSM) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets. EST View Interactive AXSM Charts. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. How the 10 Best Stocks From Last Year Hold Up Today InvestorPlace via Yahoo Finance · 1 year ago. Stock Ideas and Recommendations.
· Axsome Therapeutics rose by almost 3600% in. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Company insiders that own Axsome Therapeutics stock include Mark Coleman and Nick Pizzie. 60-Month Beta: Coefficient that measures the volatility of a stock&39;s returns relative to the market (S&P 500). 3 % based axsm stock forecast on the past 4 years of stock performance. View Insider Buying and Selling for Axsome Therapeutics.
Axsome Therapeutics earned a coverage optimism score of 2. Ladenburg Thalmann and Cantor Fitzgerald & Co. During that period the price should oscillate between -10. (AXSM) raised million axsm in an IPO on Thursday, November 19th. Axsome Therapeutics Inc Stock Forecast Over the next 52 weeks, Axsome Therapeutics Inc has on average historically risen by 277. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
320 USD at. Axsome Therapeutics stock blogger sentiment is based on 11 bloggers opinions, the blogger sentiment for AXSM is more bullish than other stocks in the Healthcare sector. Find market predictions, AXSM financials and market news. View real-time stock prices and stock quotes for a full financial overview. exchanges with a market capitalization over million. Find the latest Axsome Therapeutics, Inc. AXSM Stock Analysis Overview. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value.
See Axsome Therapeutics, Inc. Company insiders that have bought Axsome Therapeutics stock in the last two years include Mark Coleman and Nick Pizzie. InfoTrie identifies positive and negative news coverage by monitoring more than six thousand news and blog sources. analyst estimates, including AXSM earnings per share estimates and analyst recommendations. The Axsome Therapeutics stock holds a buy signal from the short-term moving average; at the same time, however, the long-term average holds a general sell signal. 34% from the latest price. 6 Wall Street analysts have issued &92;&92;"buy,&92;&92;" &92;&92;"hold,&92;&92;" and &92;&92;"sell&92;&92;" ratings for Axsome Therapeutics in the last year. 00 and a low forecast of .
Today, we will see why Axsome Therapeutics is a. Get the latest Axsome Therapeutics Inc (AXSM) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. AXSM stock outlook. 3 Top Drug Stocks to Own In By Ian Cooper Some of the biggest catalysts for future growth in drug stocks include the millions of retiring baby boomers, and new innovative. Detailed list of analyst forecasts. Axsome Therapeutics employs 29 workers across the globe. A high-level overview of Axsome Therapeutics, Inc.
Axsome Therapeutics&39; mailing address is 25 BROADWAY 9TH FLOOR, NEW YORK NY, 10004. There are currently 1 hold rating axsm stock forecast and 5 buy ratings for the stock, resulting in a consensus recommendation of &92;&92;"Buy. , Alethea Capital Management LLC, Laurion Capital Management LP, Parametric Portfolio Associates LLC, EAM Global Investors LLC, Iridian Asset Management LLC CT, Tibra Equities Europe Ltd and Citigroup Inc.
4 on InfoTrie&39;s scale. Top institutional investors include Alethea Capital Management LLC (3. · NASDAQ Updated 10:15 PM. Forecast Cash Runway: AXSM has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 36. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
6 brokerages have issued 12 month target prices for Axsome Therapeutics&39; shares. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. The average price target is 4.
Check if AXSM has a Buy or Sell Evaluation. It is based on a 60-month historical regression of the return on the stock onto the return axsm stock forecast on the S&P 500. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. AXSM stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc. AXSM detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. 28%) and EAM Global Investors LLC (0. 36, with a high forecast of 0.
(AXSM) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. The average 12-month stock price forecast for AXSM is 148. 42%), BlackRock Inc.
Find real-time AXSM - Axsome Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. · Axsome Therapeutics Inc (NASDAQ:AXSM) stock surged more than 70% yesterday after the company said its major depressive disorder drug succeeded in a late-stage study, and it plans on filing for a. 15) on an earnings per share basis. The company earns $-30,970,000.
AXSM Stock Analysis Overview What this means: Axsome Thera (AXSM) gets an Overall Rank of 52, which is an above average rank under InvestorsObserver&39;s stock ranking system. delivers machine learning based share price forecast. 8% each year Next Steps Explore more healthy companies in the Pharmaceuticals & Biotech industry. Axsome Therapeutics Inc. Despite this mind-boggling rally, there is still significant upside potential in the stock for. Popular online brokerages with access to the U.
Find the latest Earnings Report Date for Axsome Therapeutics, Inc. View Earnings Estimates for Axsome Therapeutics. Shares of AXSM can be purchased through any online brokerage account. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks.
Their predictions range from . 92% increase from the last price of . What this means: Axsome Thera (AXSM) gets an Overall Rank of 67, which is an above average rank under InvestorsObserver&39;s stock ranking system.
This suggests a possible upside of 29. 9% from the stock&39;s current price. See full list on marketbeat.
The company issued 4,300,000 shares at a price of . Based on our forecasts, a long-term increase is expected, the "AXSM" stock price prognosis foris 314. 04% to close at . Get full conversations at Yahoo Finance.
-> Vanguard total stock market index fund investor
-> Hawaiian airlines stock dividend